{"id":71505,"date":"2026-05-20T10:30:00","date_gmt":"2026-05-20T10:30:00","guid":{"rendered":"https:\/\/medsbase.com\/vip-vasoactive-intestinal-peptide\/"},"modified":"2026-05-21T07:14:08","modified_gmt":"2026-05-21T07:14:08","slug":"vip-vasoactive-intestinal-peptide","status":"publish","type":"product","link":"https:\/\/medsbase.com\/hu\/product\/vip-vasoactive-intestinal-peptide\/","title":{"rendered":"VIP (Vazoat\u00edv Intesztin\u00e1lis Peptid) \u2013 Kutat\u00e1si min\u0151s\u00e9g"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Gyors v\u00e1lasz \u2013 Mi a VIP (Vazoat\u00edv Intestin\u00e1lis Peptid)?<\/h3>\n<p style=\"margin: 0;\"><strong>VIP<\/strong> (Vazoat\u00edv Intestin\u00e1lis Peptid; CAS 40077-57-4, MW 3,325,79 g\/mol) egy szintetikus 28 aminosavas neuropeptid, amely megegyezik a term\u00e9szetes hum\u00e1n VIP-vel. Sorrend: His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH<sub>2<\/sub> (C-termin\u00e1lis amid). A <strong>VIP\/PACAP \/ secretin-glukagon szupercsal\u00e1d<\/strong>. A VIP hat a <strong>VPAC1 \u00e9s VPAC2 receptorokon<\/strong> (Gs-kapcsolt GPCR-ek) sz\u00e9les sk\u00e1l\u00e1j\u00fa fiziol\u00f3giai hat\u00e1sok kiv\u00e1lt\u00e1s\u00e1ra: erek t\u00e1gul\u00e1sa, b\u00e9l simaizom-relax\u00e1ci\u00f3ja, exokrin mirigyek elv\u00e1laszt\u00e1sa, neurotranszmitter modul\u00e1ci\u00f3, alv\u00e1s\/cirkadi\u00e1n ritmus szab\u00e1lyoz\u00e1sa, \u00e9s \u00e1ltal\u00e1nos <strong>gyullad\u00e1scs\u00f6kkent\u0151 \/ immunmodul\u00e1l\u00f3 aktivit\u00e1s<\/strong>. A publik\u00e1lt kutat\u00e1sok a VIP szerep\u00e9re \u00f6sszpontos\u00edtanak a Th2-polariz\u00e1lt immunmodul\u00e1ci\u00f3ban, autoimmun betegs\u00e9gek farmakol\u00f3gi\u00e1j\u00e1ban (RA, MS, IBD modellek), \u00e9s neuroprotekci\u00f3ban. Csak laborat\u00f3riumi kutat\u00e1si c\u00e9lra.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Mit kapsz a MedsBase-n\u00e1l:<\/strong> Liofiliz\u00e1lt \u226599% HPLC-ellen\u0151rz\u00f6tt VIP \u00b7 COA k\u00e9r\u00e9sre el\u00e9rhet\u0151 \u00b7 Diszkr\u00e9t, h\u0151m\u00e9rs\u00e9klet-stabil csomagol\u00e1s \u00b7 Vil\u00e1gszerte kutat\u00f3sz\u00e1ll\u00edt\u00e1si fut\u00e1rszolg\u00e1lat \u00b7 1,400+ hiteles\u00edtett <a href=\"https:\/\/medsbase.com\/hu\/reviews\/\">v\u00e1s\u00e1rl\u00f3i v\u00e9lem\u00e9ny<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Minden rendel\u00e9st fedez a <a href=\"https:\/\/medsbase.com\/hu\/medsbase-re-shipment-assurance-policy\/\"><strong>\u00dajrak\u00fcld\u00e9si Garancia<\/strong><\/a> \u2014 ha a csomagod nem \u00e9rkezik meg 20 munkanapon bel\u00fcl, \u00fajrak\u00fcldj\u00fck.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px;\">Specifik\u00e1ci\u00f3<\/th>\n<th style=\"padding: 8px 12px;\">R\u00e9szlet<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Vegy\u00fclet oszt\u00e1ly<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Szintetikus 28-aminosav neuropeptid; VPAC1 \/ VPAC2 receptor agonist; secretin-glukagon szupercsal\u00e1d tagja<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>CAS sz\u00e1m<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">40077-57-4 (hum\u00e1n VIP)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Szekvencia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH<sub>2<\/sub> (HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH<sub>2<\/sub>; 28 aa; C-termin\u00e1lis amid)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Molekulat\u00f6meg<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">3,325.79 g\/mol<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Molekul\u00e1ris k\u00e9plet<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>147<\/sub>H<sub>237<\/sub>N<sub>43<\/sub>O<sub>43<\/sub>S; MW 3326.78 g\/mol (28-aa szabad-amid neuropeptid).<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>\u2014 ha 20 munkanapon bel\u00fcl nem \u00e9rkezik meg, ingyenesen \u00fajrak\u00fcldj\u00fck. Ez az egyetlen h\u00e1ny\u00e1sg\u00e1tl\u00f3 kombin\u00e1ci\u00f3, amely FDA A kateg\u00f3ri\u00e1j\u00fa st\u00e1tusszal rendelkezik a terhess\u00e9g alatt, \u00e9s az ACOG, a NICE \u00e9s a SOGC els\u0151vonalbeli aj\u00e1nl\u00e1sa a terhess\u00e9gi h\u00e1nyinger \u00e9s h\u00e1ny\u00e1s kezel\u00e9s\u00e9re.<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">K\u00f6t\u0151dik <strong>VPAC1<\/strong> (sz\u00e9les eloszl\u00e1s: t\u00fcd\u0151, em\u00e9szt\u0151rendszer, T-sejtek, agy, m\u00e1j) \u00e9s <strong>VPAC2<\/strong> (simaizom, masztsejtek, k\u00f6zponti idegrendszer) hasonl\u00f3 affinit\u00e1ssal (alacsony nM K<sub>D<\/sub>). Mindk\u00e9t receptor Gs-kapcsolt \u2013 n\u00f6veli az intracellul\u00e1ris cAMP-t, aktiv\u00e1lja a PKA-t, \u00e9s sz\u00f6vet-specifikus hat\u00e1sokat v\u00e1lt ki. Alacsonyabb affinit\u00e1ssal k\u00f6t\u0151dik a PAC1 receptorhoz (a PACAP \u00e1ltal prefer\u00e1lt receptorhoz).<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Forma \/ Purity \/ T\u00e1rol\u00e1s<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofiliz\u00e1lt feh\u00e9r vagy halv\u00e1nys\u00e1rga por, \u226599% HPLC. R\u00f6vid t\u00e1v\u00fa t\u00e1rol\u00e1s: 2\u20138 \u00b0C, hossz\u00fa t\u00e1v\u00fa t\u00e1rol\u00e1s: \u221220 \u00b0C (\u226536 h\u00f3nap). Rekonstitu\u00e1lt \u00e1llapotban: 2\u20138 \u00b0C, 30 napon bel\u00fcl felhaszn\u00e1land\u00f3.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Kutat\u00e1si c\u00e9lra<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Csak laborat\u00f3riumi kutat\u00e1si c\u00e9lra. Nem szerepel a WADA tilt\u00f3list\u00e1j\u00e1n. Az Aviptadil (szintetikus VIP formul\u00e1ci\u00f3) inhal\u00e1ci\u00f3s \u00faton COVID-19-es ARDS kezel\u00e9s\u00e9re Phase III kutat\u00e1si szakaszban volt, de nem kapott szab\u00e1lyoz\u00f3i enged\u00e9lyt.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Mechanizmus \u2013 VPAC1 \/ VPAC2 farmakol\u00f3gia<\/h2>\n<ul>\n<li><strong>Du\u00e1lis VPAC1 + VPAC2 agonizmus<\/strong> \u2013 A VIP mindk\u00e9t receptorhoz hasonl\u00f3 affinit\u00e1ssal k\u00f6t\u0151dik. A VPAC1 eloszl\u00e1sa sz\u00e9les k\u00f6r\u0171 (t\u00fcd\u0151, em\u00e9szt\u0151rendszer, T-sejtek, m\u00e1jsejtek, agy). A VPAC2 els\u0151sorban a simaizomban, masztsejtekben, k\u00f6zponti idegrendszerben \u00e9s bizonyos immunsejt-popul\u00e1ci\u00f3kban koncentr\u00e1l\u00f3dik.<\/li>\n<li><strong>cAMP-PKA kask\u00e1d<\/strong> \u2014 Mindk\u00e9t VPAC receptor Gs-kapcsolt, aktiv\u00e1lja az adenil\u00e1t-cikl\u00e1zt, n\u00f6veli a cAMP szintj\u00e9t \u00e9s aktiv\u00e1lja a PKA-t. A lefel\u00e9 ir\u00e1nyul\u00f3, sz\u00f6vet-specifikus hat\u00e1sok a PKA szubsztr\u00e1t rendelkez\u00e9sre \u00e1ll\u00e1s\u00e1t\u00f3l f\u00fcggenek.<\/li>\n<li><strong>Simaizom-relax\u00e1ci\u00f3<\/strong> \u2014 A l\u00e9g\u00fati simaizmokban a VPAC2-medi\u00e1lt cAMP-n\u00f6veked\u00e9s bronchodilat\u00e1ci\u00f3t, a GI traktus simaizm\u00e1ban b\u00e9lrelax\u00e1ci\u00f3t, az \u00e9rrendszeri simaizm\u00e1ban pedig vazodilat\u00e1ci\u00f3t v\u00e1lt ki.<\/li>\n<li><strong>Th2-polariz\u00e1lt immunmodul\u00e1ci\u00f3<\/strong> \u2014 A VPAC1 aktiv\u00e1ci\u00f3ja a T-sejteken Th2-polariz\u00e1ci\u00f3t induk\u00e1l, g\u00e1tolja a Th1 citokinek (IFN-\u03b3, IL-12) termel\u00e9s\u00e9t, cs\u00f6kkenti a TNF-\u03b1\/IL-6 gyullad\u00e1sos v\u00e1laszt, \u00e9s n\u00f6veli az IL-10\/TGF-\u03b2 szab\u00e1lyoz\u00f3 citokineket. Nett\u00f3 hat\u00e1sk\u00e9nt gyullad\u00e1scs\u00f6kkent\u0151 hat\u00e1st mutat autoimmun betegs\u00e9g modellekben (reumatoid arthritis, sclerosis multiplex, gyullad\u00e1sos b\u00e9lbetegs\u00e9g, sepsis).<\/li>\n<li><strong>Mastsejt-modul\u00e1ci\u00f3<\/strong> \u2014 A VIP magas koncentr\u00e1ci\u00f3ban hisztamint szabad\u00edt fel a mastsejtekb\u0151l, de egyes k\u00f6r\u00fclm\u00e9nyek k\u00f6z\u00f6tt (koncentr\u00e1ci\u00f3- \u00e9s sz\u00f6vetf\u00fcgg\u0151 m\u00f3don) stabiliz\u00e1lhatja a mastsejt-granulumok ki\u00fcr\u00fcl\u00e9s\u00e9t.<\/li>\n<li><strong>Neuroprotekci\u00f3<\/strong> \u2014 A VPAC2 a k\u00f6zponti idegrendszer neuronjain PKA-CREB t\u00fal\u00e9l\u00e9si jel\u00e1tvitelt ind\u00edt el; publik\u00e1lt kutat\u00e1sok iszk\u00e9mi\u00e1s stroke, Parkinson-k\u00f3r \u00e9s neurodegener\u00e1ci\u00f3s modellekben dokument\u00e1lt\u00e1k a neuroprotekt\u00edv hat\u00e1sokat.<\/li>\n<li><strong>Cirkadi\u00e1n szab\u00e1lyoz\u00e1s<\/strong> \u2014 A VIP a szuprakiazmatikus mag (SCN) f\u0151 csatol\u00f3 neurotranszmittere, amely szinkroniz\u00e1lja az egyedi SCN neuronokat a koordin\u00e1lt f\u0151\u00f3r\u00e1ba, ami meghat\u00e1rozza a cirkadi\u00e1n ritmust.<\/li>\n<\/ul>\n<h2>K\u00f6zz\u00e9tett kutat\u00e1si alkalmaz\u00e1sok<\/h2>\n<ul>\n<li><strong>VPAC receptor farmakol\u00f3gia<\/strong> \u2014 kanonikus referenciavegy\u00fclet a VPAC1\/VPAC2 kutat\u00e1sban<\/li>\n<li><strong>Autoimmun betegs\u00e9g kutat\u00e1s<\/strong> \u2014 publik\u00e1lt gyullad\u00e1scs\u00f6kkent\u0151 hat\u00e1sok RA, MS, IBD \u00e9s sepsis modellekben<\/li>\n<li><strong>Pulmonol\u00f3giai kutat\u00e1s<\/strong> \u2014 Aviptadil (szintetikus VIP inhal\u00e1ci\u00f3) vizsg\u00e1lata szarkoid\u00f3zisban, t\u00fcd\u0151fibrosisban \u00e9s COVID-19 ARDS eset\u00e9n<\/li>\n<li><strong>Vazodilat\u00e1ci\u00f3s farmakol\u00f3gia<\/strong> \u2014 t\u00f6rt\u00e9nelmi kutat\u00e1s a VIP-medi\u00e1lt vascularis \u00e9s erektilis funkci\u00f3kr\u00f3l<\/li>\n<li><strong>Circadi\u00e1n ritmus kutat\u00e1s<\/strong> \u2014 SCN-h\u00e1l\u00f3zat csatol\u00e1si farmakol\u00f3gia<\/li>\n<li><strong>Th1\/Th2 polariz\u00e1ci\u00f3s kutat\u00e1s<\/strong> \u2014 a VIP kanonikus Th2-polariz\u00e1l\u00f3 peptid az IL-4 mellett<\/li>\n<li><strong>Neuroprotekci\u00f3 \/ neurodegener\u00e1ci\u00f3 kutat\u00e1s<\/strong> \u2014 ischaemi\u00e1s stroke, Parkinson- \u00e9s Alzheimer-modellek<\/li>\n<\/ul>\n<p>Kapcsol\u00f3d\u00f3 kutat\u00e1si peptid\u00e9k\u00e9rt l\u00e1sd <a href=\"https:\/\/medsbase.com\/hu\/oxytocin-acetate\/\">Oxytocin Acetate<\/a> (posterior agyalapi nonapeptid), <a href=\"https:\/\/medsbase.com\/hu\/selank\/\">Selank<\/a> (orosz fejleszt\u00e9s\u0171 neuropeptid), <a href=\"https:\/\/medsbase.com\/hu\/semax\/\">Semax<\/a> (nootrop peptid), <a href=\"https:\/\/medsbase.com\/hu\/dsip\/\">DSIP<\/a> (delta alv\u00e1st el\u0151id\u00e9z\u0151 peptid), <a href=\"https:\/\/medsbase.com\/hu\/thymosin-alpha-1\/\">Thymosin Alpha-1<\/a> (immunmodul\u00e1tor). B\u00f6ng\u00e9ssze a teljes <a href=\"https:\/\/medsbase.com\/hu\/peptides\/\">peptid kutat\u00e1si katal\u00f3gust<\/a>.<\/p>\n<h2>El\u00e9rhet\u0151 er\u0151ss\u00e9gek<\/h2>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px;\">Ampulla er\u0151ss\u00e9ge<\/th>\n<th style=\"padding: 10px;\">Csomagm\u00e9ret<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong> \u2014 szabv\u00e1nyos kutat\u00e1si er\u0151ss\u00e9g<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 vagy 20 flakon<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong> \u2014 kiterjesztett protokollok, alacsonyabb mg-enk\u00e9nti k\u00f6lts\u00e9g<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 vagy 20 flakon<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 14px 18px; margin: 18px 0;\"><strong class=\"mb-bac-water-callout\">\ud83d\udca7 BAC v\u00edzre van sz\u00fcks\u00e9ge?<\/strong> B\u00e1rmilyen liofiliz\u00e1lt flakon rekonstitu\u00e1l\u00e1s\u00e1hoz sterilis bakt\u00e9riosztatikus v\u00edz sz\u00fcks\u00e9ges. P\u00e1ros\u00edtsa ezt a term\u00e9ket a <a href=\"\/hu\/bac-water\/\"><strong>BAC Water (Bakteriosztatikus V\u00edz)<\/strong><\/a> \u2014 30 mL t\u00f6bbadagos flakonnal, 0,9% benzil-alkohol tartalm\u00fa, USP-min\u0151s\u00e9g\u0171.<\/div>\n<h2>T\u00e1rol\u00e1s \u00e9s rekonstit\u00faci\u00f3<\/h2>\n<p>Liofiliz\u00e1lt 2\u20138 \u00b0C r\u00f6vid t\u00e1von, \u221220 \u00b0C hossz\u00fa t\u00e1von. Rekonstitu\u00e1l\u00e1s bakt\u00e9riosztatikus v\u00edzzel (1,0 mL 5\/10 mg-os \u00fcvegcs\u00e9re \u2192 5 \/ 10 mg\/mL). Ker\u00fclje a fagyaszt\u00e1s-olvad\u00e1s ciklusokat. A VIP oxid\u00e1ci\u00f3ra \u00e9rz\u00e9keny a Met-17 marad\u00e9kn\u00e1l \u2013 v\u00e9dje a rekonstitu\u00e1lt oldatokat a hossz\u00fa leveg\u0151hat\u00e1st\u00f3l.<\/p>\n<h2>GYIK<\/h2>\n<h3>A VIP ugyanaz, mint a PACAP?<\/h3>\n<p>Nem \u2013 rokon peptidok (ugyanabban a szupercsal\u00e1dban), de k\u00fcl\u00f6nb\u00f6z\u0151 molekul\u00e1k. A PACAP-38 \u00e9s PACAP-27 ugyanazon VPAC1\/VPAC2 receptorok alternat\u00edv ligandjai (PAC1 szelektivit\u00e1ssal, amit a VIP nem mutat). A VIP \u00e9s PACAP szekvenciaazonoss\u00e1ga ~68%.<\/p>\n<h3>Milyen d\u00f3zistartom\u00e1nyokat haszn\u00e1lnak a kutat\u00e1sokban?<\/h3>\n<p>R\u00e1gcs\u00e1l\u00f3k in-vivo protokolljai \u00e1ltal\u00e1ban 1\u201310 nmol\/kg SC vagy IP adagot alkalmaznak. In-vitro munk\u00e1kban nanomol\u00e1ris koncentr\u00e1ci\u00f3kat haszn\u00e1lnak. Az Aviptadil klinikai inhal\u00e1ci\u00f3s adagol\u00e1sa COVID-19 kutat\u00e1sban 100 \u00b5g naponta 3 alkalommal volt.<\/p>\n<h3>Mi\u00e9rt r\u00f6vid a VIP plazmafelez\u00e9si ideje?<\/h3>\n<p>A VIP-t gyorsan lebontja a semleges endopeptid\u00e1z (NEP) \u00e9s m\u00e1s peptid\u00e1zok, k\u00f6r\u00fclbel\u00fcl 2 perces plazmafelez\u00e9si id\u0151vel. Ez\u00e9rt a SC\/IP adagol\u00e1s a szabv\u00e1nyos kutat\u00e1si \u00fatvonal; az inhal\u00e1ci\u00f3s adagol\u00e1s (Aviptadil) megker\u00fcli a first-pass plazmaclearance-t t\u00fcd\u0151indik\u00e1ci\u00f3k eset\u00e9n.<\/p>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 20px 0 8px; border-radius: 4px; font-size: 14px;\"><strong>Mi\u00e9rt \u00e9rdemes kutat\u00e1si vegy\u00fcleteket rendelni a MedsBase-t\u0151l:<\/strong> Liofiliz\u00e1lt HPLC \u226599%-os peptidok \u00e9s vegy\u00fcletek \u00b7 COA k\u00e9r\u00e9sre el\u00e9rhet\u0151 \u00b7 Diszkr\u00e9t, h\u0151m\u00e9rs\u00e9klet-stabil csomagol\u00e1s \u00b7 Vil\u00e1gszerte fut\u00e1r \u00b7 <a href=\"https:\/\/medsbase.com\/hu\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance<\/a> minden rendel\u00e9sre \u00b7 1.400+ ellen\u0151rz\u00f6tt <a href=\"https:\/\/medsbase.com\/hu\/reviews\/\">v\u00e1s\u00e1rl\u00f3i v\u00e9lem\u00e9ny<\/a><\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Egy\u00e9b neuropeptid \/ immunol\u00f3giai kutat\u00e1si peptidok<\/h2>\n<ul>\n<li><a href=\"\/hu\/oxytocin-acetate\/\"><strong>Oxytocin Acetate<\/strong><\/a> \u2014 Poszterior agyalapi nonapeptid<\/li>\n<li><a href=\"\/hu\/selank\/\"><strong>Selank<\/strong><\/a> \u2014 Orosz anxiolitikus neuropeptid<\/li>\n<li><a href=\"\/hu\/dsip\/\"><strong>DSIP<\/strong><\/a> \u2014 Delta-alv\u00e1st el\u0151seg\u00edt\u0151 peptid<\/li>\n<li><a href=\"\/hu\/thymosin-alpha-1\/\"><strong>Thymosin Alpha-1<\/strong><\/a> \u2014 Immunmodul\u00e1l\u00f3 peptid (Th1 polariz\u00e1ci\u00f3; komplementer)<\/li>\n<li><a href=\"\/hu\/ll-37-cathelicidin-antimicrobial-peptide\/\"><strong>LL-37 (Cathelicidin)<\/strong><\/a> \u2014 Vel\u0151szerzett immunrendszeri antimikrobi\u00e1lis peptid<\/li>\n<li><a href=\"\/hu\/bac-water\/\"><strong>BAC Water (Bakteriosztatikus V\u00edz)<\/strong><\/a> \u2014 Sz\u00fcks\u00e9ges minden liofiliz\u00e1lt flakon rekonstitu\u00e1l\u00e1s\u00e1hoz \u2014 steril, 0.9% benzil-alkohollal tart\u00f3s\u00edtott h\u00edg\u00edt\u00f3oldat<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Szintetikus 28 aminosavas hum\u00e1n neuropeptid (VIP\/PACAP csal\u00e1d, szekretin-glukagon szupercsal\u00e1d)<br \/>\n\u2705 VPAC1 + VPAC2 receptor agonist (Gs-kapcsolt GPCR-ek) \u2192 cAMP-PKA kaszk\u00e1d<br \/>\n\u2705 \u00c9rkit\u00e1g\u00edt\u00e1s, simaizom-relax\u00e1ci\u00f3, Th2-polariz\u00e1lt immunmodul\u00e1ci\u00f3<br \/>\n\u2705 A szuprakiasztmatikus mag cirkadi\u00e1n ritmus\u00e1nak f\u0151 kapcsol\u00f3 neurotranszmittere<br \/>\n\u2705 CAS 40077-57-4; MW 3,325.79; C-termin\u00e1lis amid<\/p>\n<p><strong>VIP (Vazoakt\u00edv Intestin\u00e1lis Peptid)<\/strong> szintetikus 28 aminosavas hum\u00e1n neuropeptidot tartalmaz.<\/p>","protected":false},"featured_media":71532,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6557,6494,6558,6554,6553,6555,6556],"class_list":{"0":"post-71505","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptides","7":"product_tag-neuropeptide","8":"product_tag-research-peptide","9":"product_tag-th2-immune-modulator","10":"product_tag-vasoactive-intestinal-peptide","11":"product_tag-vip","12":"product_tag-vpac1-agonist","13":"product_tag-vpac2-agonist","15":"first","16":"instock","17":"shipping-taxable","18":"purchasable","19":"product-type-variable","20":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product\/71505","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/comments?post=71505"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media\/71532"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media?parent=71505"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_brand?post=71505"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_cat?post=71505"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_tag?post=71505"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}